Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Pharmacopsychiatry
|
May 1, 1993
Adverse psychic reactions to psychotropic drugs--a report from the AMUP study
R Grohmann, C Ströbel, E Rüther, et al.
Clinical Neuropharmacology
|
January 1, 1992
Controlled MRI studies in psychiatric patients--relations to functional imaging methods (EEG mapping, SPECT and PET)
W Günther, T Vogl, C Haag, et al.
Pharmacopsychiatry
|
January 1, 1995
Report on the sixth consensus conference on the methodology of clinical trials with hypnotic drugs
J Angst, A Borbely, R R Engel, et al.
Neuropsychobiology
|
January 1, 1984
Antipsychotic efficacy of fluperlapine. An open multicenter trial
B Woggon, J Angst, M Bartels, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo
G B Cassano, C Toni, A Petracca, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 23, 2005
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences
D Zullino, G Mayland, L G Schmidt, et al.
Journal of Acquired Immune Deficiency Syndromes
|
March 1, 1993
HIV-related ocular microangiopathic syndrome and cognitive functioning
S A Geier, C Perro, V Klauss, et al.
Acta Psychiatrica Belgica
|
September 1, 1972
A new comparative physiognomy of neuroleptics: a collaborative clinical report
J Bobon, D P Bobon, A Pinchard, et al.
Pharmacopsychiatry
|
September 1, 1991
Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs
J Angst, P Bech, D Bobon, et al.
Pharmacopsychiatry
|
July 1, 1990
Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee
L Amaducci, J Angst, P Bech, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Pharmacopsychiatry
|
May 1, 1993
Adverse psychic reactions to psychotropic drugs--a report from the AMUP study
R Grohmann, C Ströbel, E Rüther, et al.
Clinical Neuropharmacology
|
January 1, 1992
Controlled MRI studies in psychiatric patients--relations to functional imaging methods (EEG mapping, SPECT and PET)
W Günther, T Vogl, C Haag, et al.
Pharmacopsychiatry
|
January 1, 1995
Report on the sixth consensus conference on the methodology of clinical trials with hypnotic drugs
J Angst, A Borbely, R R Engel, et al.
Neuropsychobiology
|
January 1, 1984
Antipsychotic efficacy of fluperlapine. An open multicenter trial
B Woggon, J Angst, M Bartels, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
March 1, 1994
Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo
G B Cassano, C Toni, A Petracca, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
July 23, 2005
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences
D Zullino, G Mayland, L G Schmidt, et al.
Journal of Acquired Immune Deficiency Syndromes
|
March 1, 1993
HIV-related ocular microangiopathic syndrome and cognitive functioning
S A Geier, C Perro, V Klauss, et al.
Acta Psychiatrica Belgica
|
September 1, 1972
A new comparative physiognomy of neuroleptics: a collaborative clinical report
J Bobon, D P Bobon, A Pinchard, et al.
Pharmacopsychiatry
|
September 1, 1991
Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs
J Angst, P Bech, D Bobon, et al.
Pharmacopsychiatry
|
July 1, 1990
Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee
L Amaducci, J Angst, P Bech, et al.
Page
of 15